N2 Response to Clinical Trials Regulatory Modernization Initiative


Written by Barbara Brown

August 15, 2021

As part of N2’s strategic priority to “Position N2 as a national voice for clinical research in Canada,” N2 submitted this letter of input on behalf of its membership organizations to Health Canada in response to its consultation call for its Clinical Trials Regulatory Modernization Initiative.

Read Letter Here

You May Also Like…

Message from N2

Message from N2

The following message is shared together with Karen Arts’s family. With profound sadness, we share the news that Karen...